Identifying Global Oncology KOLs

Situation

In 2023, an EU-based biotech company in the oncology space was looking to build its US presence and global KOL relationships because most of its clinical trials had been conducted in the EU. Additionally, they were seeking to expand their database of experts in 6 EU countries and Australia. These experts would be considered for clinical trial investigators, advisors, and other consultant roles to the client company.

Task

ClinicalMind planned to identify up to 200 melanoma experts in the US and global locations.

The database would use existing lists that the client provided as well as client recommendations for other data sources they viewed as ideal (committees or organizations that might be of interest) as well as what to avoid in terms of criteria.

Action

Using criteria defined by the client and ClinicalMind’s data analytics and medical teams, we began identifying relevant KOLs from our available pipeline data sources (>100 profile fields).

Ranking criteria, as defined by the client during project kickoff, were applied to the expert list. Scoring criteria included, for example, the importance of work, niche/area of focus, and networks of peer influence.

Result

A sortable compendium of approximately 200 experts was developed and provided to the client in Excel.

Additionally, a PowerPoint slide deck was developed to highlight the top 50 experts. Each expert’s profile included their photo, name, degree, affiliation, and location; a brief biography, education, and training, link to key publications, clinical and research interests, and any leadership roles they hold.